Glostrup University Hospital, Copenhagen
Clinical trials sponsored by Glostrup University Hospital, Copenhagen, explained in plain language.
-
Could a gut bacteria byproduct shield MS patients from relapses?
Disease control Recruiting nowThis study tests whether a daily supplement of indole-3-propionic acid (IPA), a natural substance made by gut bacteria, can help people with relapsing-remitting multiple sclerosis (RRMS). Researchers will track 220 adults over 27 months to see if IPA reduces relapses, brain lesio…
Phase: NA • Sponsor: Glostrup University Hospital, Copenhagen • Aim: Disease control
Last updated May 26, 2026 03:46 UTC
-
New support program aims to ease burden on caregivers of frail seniors with arthritis
Symptom relief Recruiting nowThis study tests a new support program called INSPIRE for unpaid caregivers of older adults (65+) who have both rheumatoid arthritis and frailty. The program offers personalized help over about 12 weeks, including emotional support, practical advice, and guidance on navigating he…
Phase: NA • Sponsor: Glostrup University Hospital, Copenhagen • Aim: Symptom relief
Last updated May 26, 2026 03:44 UTC
-
New program aims to empower arthritis patients from day one
Symptom relief Recruiting nowThis study tests a nurse-led self-management program for 130 adults recently diagnosed with inflammatory arthritis (like rheumatoid arthritis or psoriatic arthritis). Participants will either get the program plus usual care or usual care alone. The goal is to see if the program h…
Phase: NA • Sponsor: Glostrup University Hospital, Copenhagen • Aim: Symptom relief
Last updated May 26, 2026 03:30 UTC